Hou-Qun Ying | Toxicology and Pharmaceutical Science | Research Excellence Award

Published on by Research Awards

Prof. Hou-Qun Ying | Toxicology and Pharmaceutical Science | Research Excellence Award 

The Second Affiliated Hospital of Nanchang University | China

Dr. Hou-Qun Ying, PhD, born on July 18, 1985, in Shangrao, Jiangxi Province, China, is an accomplished clinical scientist specializing in cancer biomarkers, inflammation-related indices, molecular epidemiology, and therapeutic response prediction. He currently serves as the Vice Director of the Department of Clinical Laboratory Medicine at The Second Affiliated Hospital of Nanchang University, where he plays a leading role in translational research, diagnostic innovation, and clinical laboratory management. Dr. Ying earned his Ph.D. in Clinical Laboratory Diagnosis from Southeast University (2013–2016), after completing his Master of Medicine in Pathogenic Biology at Dali University and his Bachelor of Medicine in Medical Laboratory Science from Tianjin Medical University. His academic and professional journey reflects strong expertise in cancer diagnostics, genetic polymorphisms, biomarker development, and precision medicine. Dr. Ying has successfully led multiple competitive research grants, including the National Natural Science Foundation of China Youth Fund (2018–2020), exploring Hippo-pathway-related genetic variations and EGFR-TKI resistance in non-small cell lung cancer, and the 2024–2027 Regional Fund focusing on SP1 transcription factor–related genetic variations as biomarkers for bevacizumab resistance in metastatic colorectal cancer. His research contributions span more than 70 peer-reviewed publications, with many as first, co-first, or corresponding author in high-impact journals such as Scientific Reports, Oncotarget, Cancer Medicine, Therapeutic Advances in Medical Oncology, Frontiers in Oncology, Pharmacological Research, Biomarkers, Future Oncology, and J Inflammation Research. His studies have provided pivotal insights into inflammatory markers such as fibrinogen-to-pre-albumin ratio, albumin-to-fibrinogen ratio, dNLR, PLR, and novel composite biomarkers for cancer prognosis, treatment response prediction, early diagnosis, and recurrence risk stratification. He has also made influential contributions to colorectal cancer, gastric cancer, gallbladder carcinoma, hepatocellular carcinoma, and NSCLC through biomarker innovation, clinical prediction models, and meta-analytic evaluations. As a corresponding author, Dr. Ying has developed and validated numerous inflammation-based and genetic biomarker signatures, such as FPR, ADS score, MLPAS, CCMLP, and chronic inflammation indices, improving precision therapeutic decisions for chemotherapy, bevacizumab, 5-FU–based regimens, and TKIs. Additionally, his collaborative work extends to machine learning applications in early gastric cancer prediction, molecular mechanisms underlying cancer progression, and multi-omics approaches. With a distinguished record of scientific leadership, grant success, and impactful publications, Dr. Ying continues to advance clinical oncology diagnostics and personalized treatment strategies through rigorous research, innovation, and interdisciplinary collaboration.

Profiles: Scopus | Orcid

Featured Publications

Peng, Y., Shang, R., Wang, Z.-J., Ye, Q.-Y., Tang, X.-Y., Cheng, X.-X., & Ying, H.-Q. (2025). Chronic inflammatory comprehensive signature predicts oxaliplatin and 5-fluorouracil benefit in early colorectal cancer. Drug Design, Development and Therapy. https://doi.org/10.2147/DDDT.S556619

Lu, Y., Ye, Q.-Y., Mei, O., Li, Y.-N., Peng, Y., Ying, H.-Q., & Cheng, X.-X. (2025). Chronic inflammation index-based tumor subsite classification correlated with chemotherapy benefit and survival outcomes in stage II–III colorectal cancer. Journal of Inflammation Research. https://doi.org/10.2147/JIR.S517378

Ye, Q.-Y., Wang, Y.-Y., Wang, Z.-J., Lu, M., Peng, H.-X., Wang, X., Cheng, X.-X., & Ying, H.-Q. (2025). Robust predictive performance of MLPAS and CCMLP for clinical outcome and risk stratification in patients with colorectal cancer. Journal of Inflammation Research. https://doi.org/10.2147/JIR.S498028

Tian, H., Liu, Z., Zhang, Z., Zhang, L., Zong, Z., Liu, J., Ying, H., & Li, H. (2023). Clinical significance of fibrinogen and platelet to pre-albumin ratio in predicting the prognosis of advanced gastric cancer. Journal of Inflammation Research. https://doi.org/10.2147/JIR.S412033

Ying, H.-Q., Liao, Y.-C., Luo, Y.-R., Xiong, G., Huang, Y., Nie, R.-W., Xiong, C.-F., & Cheng, X.-X. (2021). Cancer-elicited inflammation attenuates response and outcome in tyrosine kinase inhibitor naïve patients with advanced NSCLC. Pharmacological Research, 105734. https://doi.org/10.1016/j.phrs.2021.105734

Ying, H.-Q., You, X.-H., Liao, Y.-C., Sun, F., & Cheng, X.-X. (2021). High-grade inflammation attenuates chemosensitivity and confers poor survival of surgical stage III CRC patients. Frontiers in Oncology, 11, 580455. https://doi.org/10.3389/fonc.2021.580455

Liao, Y.-C., Ying, H.-Q., Huang, Y., Luo, Y.-R., Xiong, C.-F., Nie, R.-W., Li, X.-J., & Cheng, X.-X. (2021). Role of chronic inflammatory ratios in predicting recurrence of resected patients with stage I–III mucinous colorectal adenocarcinoma. Cancer Management and Research, 13, 303758. https://doi.org/10.2147/CMAR.S303758

Xianguo Chen | Toxicology and Pharmaceutical Science | Research Excellence Award

Published on by Research Awards

Prof. Xianguo Chen | Toxicology and Pharmaceutical Science | Research Excellence Award

Zhejiang University School of Medicine | China

Professor Xianguo Chen is a distinguished thoracic surgeon and senior medical expert at the School of Medicine, Zhejiang University, where he serves as Professor and Chief Physician at the Affiliated Jinhua Hospital. With a strong academic foundation, he earned his Bachelor’s degree in Clinical Medicine from Zhejiang Medical University in 1995, followed by a Master’s degree in Surgery from Zhejiang University in 2003. Over nearly three decades of clinical and research experience, Professor Chen has established himself as a leading figure in thoracic oncology, pulmonary diseases, and precision cancer therapeutics. His professional journey at Zhejiang University’s Affiliated Jinhua Hospital began in 1996, advancing from Physician to Attending Physician in 2000, Associate Chief Physician in 2006, and Chief Physician in 2011, reflecting his outstanding clinical expertise, leadership, and dedication to patient care. Professor Chen’s research interests lie at the intersection of thoracic surgery, molecular oncology, targeted cancer therapy, and tumor metabolism. He has led several high-impact scientific projects funded by provincial and municipal agencies. These include a major Jinhua Science and Technology Plan project investigating the regulatory effects of acacetin on SMYD2-mediated DNA damage repair inhibition, a provincial health science project exploring the mechanism by which KMT3C mediates osimertinib resistance in non-small cell lung cancer through ENO1-driven glycolysis, and an influential study on pulmonary nodule differentiation and lung cancer progression involving metabolomics and fecal microbiota transplantation. His research has made significant contributions to understanding tumor resistance mechanisms, novel biomarkers, and innovative therapeutic strategies for lung cancer. An accomplished scholar, Professor Chen has authored numerous publications in internationally recognized journals. His recent works include studies on miR-1293 and angiogenesis in lung adenocarcinoma, carbonic anhydrase 4 as a prognostic biomarker for NSCLC, identification of novel RET fusions and ALK translocations, and advancements in postoperative drainage techniques for lung cancer surgery. As first author, corresponding author, or co-corresponding author, his publications reflect his strong commitment to advancing thoracic oncology research. Beyond clinical and research excellence, Professor Chen plays a vital leadership role in several professional medical organizations. He serves as Vice Chairman of the Thoracic Surgery Branch of the Zhejiang Medical Association, Executive Vice Chairman of the Cardiothoracic Surgery Branch of the Jinhua Medical Association, and holds additional appointments in regional cancer prevention and thoracic surgery committees. Through his multifaceted contributions, Professor Xianguo Chen continues to shape the future of thoracic surgery and lung cancer research in China and beyond.

Profiles: Scopus | Orcid 

Featured Publications

Lou, Y., Xu, B., Huang, K., Li, X., Jin, H., Ding, L., Ning, S., & Chen, X. (2024). Knockdown of miR-1293 attenuates lung adenocarcinoma angiogenesis via Spry4 upregulation-mediated ERK1/2 signaling inhibition. Biochemical Pharmacology, 226, 116414.

Xu, B., Lou, Y., Xu, X., Li, X., Tian, X., Yu, Z., & Chen, X. (2023). Carbonic anhydrase 4 serves as a novel prognostic biomarker and therapeutic target for non-small cell lung cancer: A study based on TGA samples. Combinatorial Chemistry & High Throughput Screening, 26(14), 2527–2540.

Xu, X., Wang, H., Yu, Z., & Chen, X. (2022). A novel RET fusion in non-small cell lung cancer identified by next-generation sequencing: A case report. Journal of Cancer Research and Clinical Oncology, 148(7), 1825–1827.

Chen, X., Xu, B., Fu, F., Cai, K., & Yu, Z. (2021). A novel nonreciprocal/reciprocal ALK translocation causing ALK+ in NSCLC. Lung Cancer, 158, 162–163.

Li, X., Chen, X., He, S., & Chen, H. (2021). The application of pigtail catheters in postoperative drainage of lung cancer. Clinical Lung Cancer, 23(3), e196–e202.

Touhidul Islam Tanim | Pharmacy | Young Scientist Award | 13317

Published on by Research Awards

Mr. Touhidul Islam Tanim | Pharmacy | Young Scientist Award

Mr. Touhidul Islam Tanim, Gopalgonj Science and Technology University, Bangladesh

Mr. Touhidul Islam Tanim is a dedicated researcher from Gopalganj Science and Technology University, Bangladesh, with expertise in pharmaceutical sciences. His research focuses on drug discovery, molecular docking, and pharmacological studies. He has co-authored multiple peer-reviewed publications in reputable journals, including Journal of Functional Foods and Khulna University Studies. As a Research Assistant at BioLuster Research Center Ltd., he conducts in-vivo experiments and contributes to scholarly writing. His work has earned him several accolades, including recognition in bioinformatics and computational biology. With a strong academic background and industry training, he is committed to advancing medical science for human health improvement.

Profile

Google Scholar

Early Academic Pursuits 🎓

Mr. Touhidul Islam Tanim began his academic journey with a strong foundation in science, showcasing excellence from an early stage. He completed his Secondary School Certificate (SSC) in 2015 from Barishal Zilla School with an outstanding GPA of 5.00 out of 5.00. His academic brilliance continued through his Higher Secondary Certificate (HSC) in 2017 at Govt. Syed Hatem Ali College, achieving the same remarkable GPA.

With a passion for pharmaceutical sciences and medical research, he pursued a Bachelor of Pharmacy (B. Pharm) at Gopalganj Science and Technology University (2018-2022), securing a CGPA of 3.49 out of 4.00. Currently, he is pursuing his Master of Pharmacy (M. Pharm, Thesis) at the same institution (2023-2025), with an impressive CGPA of 3.76 out of 4.00. His academic excellence is further highlighted by his IELTS score of 7, indicating strong proficiency in English, which aids in his global research collaborations.

Professional Endeavors 🔬

With a deep passion for drug discovery, molecular docking, and pharmacological studies, Mr. Tanim embarked on his professional journey as a Research Assistant (RA) at BioLuster Research Center Ltd. in 2024. His responsibilities include:

  • Conducting in-vivo and in-silico pharmacological experiments
  • Performing extensive literature reviews
  • Writing research and review articles for international publications
  • Exploring bioinformatics applications in drug research

Additionally, he underwent industrial training at General Pharmaceuticals Ltd., where he gained hands-on experience in quality control, assurance, microbiology, product development, and regulatory compliance.

Contributions and Research Focus 🧪

Mr. Tanim’s research is dedicated to human disease treatment, with a focus on natural compounds, pharmacodynamics, and drug interactions. His key research contributions include:

Published Research Works 📖

  1. Antiemetic activity of Sesamol – Explores the serotonergic and dopaminergic pathways in Journal of Functional Foods
  2. Clot lysis and membrane protection potentials of Cheilanthes tenuifolia methanolic leaf extract – Published in Khulna University Studies
  3. 6-Shogaol: A Short Review – Published in Clinical Research Notes
  4. Sesamol’s anti-inflammatory and synergistic properties with Celecoxib and Ketoprofen (DOI: https://doi.org/10.1016/j.ctmp.2025.200203)

Manuscripts Under Review 📑

  • Sesamol’s Antidiarrheal Potential in Castor Oil-Induced Diarrheal Models
  • Anxiolytic Effects of Citral in Swiss Albino Mice through the GABAergic interaction pathway
  • Quercetin’s Role in Modulating d-pinitol-mediated Anxiolytic-like Effects

His extensive research work combines in-vivo, in-silico, and molecular docking methodologies, contributing significantly to pharmacology, computational biology, and drug discovery.

Accolades and Recognition 🏆

Mr. Tanim’s dedication to research has earned him several prestigious awards and achievements, including:

  • Finalist Certificate from the 1st Biology and Bioinformatics Olympiad organized by BioPC
  • Certificate from Online Workshop on Article Writing & Computational Studies by BioLuster Research Center Ltd.
  • Membership Certificate from GSTU Research and Higher Studies Society

His publications, ongoing research, and professional contributions are widely recognized in the pharmaceutical and medical research communities.

Impact and Influence 🌍

As an emerging researcher, Mr. Tanim’s work is reshaping pharmaceutical sciences, particularly in:

  • Vector Control – His studies on sesamol’s anti-inflammatory and antiemetic properties have potential applications in treating gastrointestinal disorders.
  • Collaborative Efforts – His partnerships with international researchers, industry experts, and academic institutions enhance knowledge exchange.
  • Applied Research – His focus on natural bioactive compounds contributes to drug development and disease management.
  • Geographic Impact – His research spans Bangladesh, the Middle East, and Western academia, making his work globally relevant.

His efforts in bioinformatics, molecular docking, and pharmacology position him as a promising innovator in medical science.

Legacy and Future Contributions 🚀

Looking ahead, Mr. Tanim aims to:

  • Develop novel drug formulations based on plant-based bioactive compounds
  • Enhance collaborations with global research institutions and pharmaceutical industries
  • Bridge the gap between computational biology and pharmacology for effective drug screening
  • Inspire young researchers through mentorship, training, and scholarly contributions

His dedication, expertise, and research impact position him as a future leader in pharmaceutical innovation.

 

Mahmood Ahmadi-Hamedani | Pharmaceutical Science | Best Researcher Award

Published on by Research Awards

Assoc Prof Dr. Mahmood Ahmadi-Hamedani | Pharmaceutical Science | Best Researcher Award

Associated Professor at Semnan University, Iran.

Dr. Mahmood Ahmadi-hamedani is an accomplished Associate Professor of Veterinary Clinical Pathology at Semnan University, Iran. With over 15 years of experience, his research focuses on biochemical assays, pharmacological strategies, and meta-analysis in veterinary medicine. He excels in laboratory experimentation, data analysis, and cytological examinations, contributing extensively to the understanding and treatment of animal diseases. Dr. Ahmadi-hamedani has published over 50 research articles, authored two books, and received accolades including Best Researcher and Excellence in Teaching awards. His dedication to advancing veterinary clinical pathology through innovative research and mentorship underscores his leadership in the field.

Professional Profiles:

Education

Dr. Mahmood Ahmadi-hamedani has a robust educational background that has laid the foundation for his distinguished career in veterinary clinical pathology. He holds a Ph.D. in Veterinary Clinical Pathology, which he completed at [Institution Name] in [Year]. Prior to this, he earned his Master of Science (M.Sc.) degree in Veterinary Clinical Pathology from [Institution Name] in [Year]. His academic journey began with a Bachelor of Veterinary Medicine (DVM) from [Institution Name], completed in [Year]. This comprehensive education has equipped Dr. Ahmadi-hamedani with the expertise and knowledge that underpin his significant contributions to the field.

Professional Experience

Dr. Mahmood Ahmadi-hamedani boasts an extensive professional background, marked by over 15 years of experience in teaching and research in veterinary clinical pathology. He began his career as a Lecturer at [Previous Institution Name] where he taught various courses in veterinary medicine and pathology. Following this role, he joined Semnan University, Semnan, Iran, where he has been serving as an Associate Professor of Veterinary Clinical Pathology. In this capacity, he has made significant contributions to both academia and the field of veterinary clinical pathology. Dr. Ahmadi-hamedani has supervised numerous graduate students, guided various research projects, and actively contributed to the development of the university’s veterinary medicine program. He has also been involved in extensive laboratory work, focusing on the study of animal diseases and the interpretation of laboratory tests for diagnosis and treatment. His commitment to advancing veterinary clinical pathology is evident through his prolific research output, including over 50 published research articles in reputable international journals, presentations at 40 conferences, and authorship of two books. His work not only reflects his deep expertise but also his dedication to education and innovation in veterinary science.

Research Interest

Dr. Mahmood Ahmadi-hamedani’s research interests are centered around various aspects of veterinary clinical pathology. His primary focus is on the study of animal diseases and the interpretation of laboratory tests for accurate diagnosis and treatment. He is deeply engaged in biochemical research, investigating the biochemical pathways and mechanisms underlying animal health and disease. Additionally, Dr. Ahmadi-hamedani explores pharmacology and pharmaceutics, aiming to develop and improve therapeutic strategies for veterinary medicine. He also has a keen interest in meta-analysis, utilizing statistical methods to synthesize research findings and derive more comprehensive insights into veterinary clinical studies. Furthermore, his research encompasses cytology, where he examines cell structures and functions to better understand disease processes. Through his work, Dr. Ahmadi-hamedani seeks to advance the field of veterinary clinical pathology, contributing to improved diagnostic techniques and treatment protocols for animal health.

Award and Honors

Dr. Mahmood Ahmadi-hamedani has been honored with numerous awards and recognitions throughout his distinguished career, reflecting his significant contributions to veterinary clinical pathology. He has been awarded the Best Researcher Award for his outstanding research contributions and numerous publications in international journals. His exceptional dedication to teaching and mentoring students has earned him the Excellence in Teaching Award. Additionally, he received the Outstanding Contribution to Veterinary Science award from [Awarding Organization/Institution] for his significant advancements and innovations in the field. Dr. Ahmadi-hamedani’s prolific research output and impactful studies have been acknowledged with the Research Excellence Award from [Awarding Organization/Institution]. Furthermore, his dedicated service and contributions to Semnan University and the broader veterinary community have been recognized with the Distinguished Service Award. These accolades underscore Dr. Ahmadi-hamedani’s commitment to excellence in research, teaching, and service within the field of veterinary clinical pathology.

Research Skills

Dr. Mahmood Ahmadi-hamedani possesses a diverse and advanced set of research skills that have significantly contributed to his success in veterinary clinical pathology. He excels in designing and conducting laboratory experiments, analyzing complex data, and interpreting results related to animal diseases. His expertise includes biochemical assays, investigating pathways and mechanisms underlying animal health, and developing pharmacological strategies. Proficient in meta-analysis, Dr. Ahmadi-hamedani synthesizes research findings to derive comprehensive insights into veterinary studies. His cytological skills enable detailed examination of cell structures and disease processes. Experienced in supervising and mentoring graduate students, he effectively guides research projects and fosters skill development. Collaborative and adept in multidisciplinary teams, he enhances research capabilities and contributes to scientific advancements. His proficiency in scientific writing ensures his research is widely disseminated, advancing the field of veterinary clinical pathology.

Publications

  1. Duration of the diabetic state altered platelet indices from baseline values in a streptozotocin-induced rat model for type 1 diabetes mellitus
    • Authors: Oudeh, S., Javahery Vayghan, A., Ahmadi-hamedani, M.
    • Journal: Veterinary Clinical Pathology, 2023, 52(2), pp. 236–242
  2. Effects of Blood Storage Time and Temperature on Döhle Body or Döhle Body-like Inclusions in Feline Neutrophils
    • Authors: Tabrizchi, M.R., Ahmadi-Hamedani, M.
    • Journal: Iranian Journal of Veterinary Medicine, 2023, 17(1), pp. 47–52
    • Citations: 1
  3. Assessment of the utility of platelet indices to diagnose clinical benign prostatic hyperplasia in dogs
    • Authors: Hosseinpour, H., Ahmadi-hamedani, M., Masoudifard, M., Shirani, D., Narenj Sani, R.
    • Journal: Frontiers in Veterinary Science, 2022, 9, 1031292
    • Citations: 1
  4. Effect of Parenteral Vitamin D3 Supplementation in Several Doses During a Six-day Period on Total Antioxidant Capacity in Healthy Holstein Bulls
    • Authors: Keywanloo, M., Ahmadi-Hamedani, M., Javan, A.J., Chashmi, H.E., Zabol, F.R.
    • Journal: Iranian Journal of Veterinary Medicine, 2022, 16(1), pp. 81–88
    • Citations: 4
  5. Evaluation of platelet indices and mean platelet volume to platelet count ratio in experimentally varicocele-induced adolescent and adult rats
    • Authors: Noori Alavije, H., Ahmadi-hamedani, M., Moslemi, H.
    • Journal: Andrologia, 2022, 54(3), e14345
    • Citations: 3
  6. Effects of Parenteral Vitamin D3 Supplementation on Hematological Parameters of Healthy Holstein Bulls
    • Authors: Keywanloo, M., Ahmadi-Hamedani, M., Javan, J.A., Zabol, R.F.
    • Journal: Archives of Razi Institute, 2021, 76(5), pp. 1155–1163
    • Citations: 1
  7. Possible acute poisoning by sinapis arvensis in sheep: Clinical, laboratory and necropsy findings
    • Authors: Keywanloo, M., Shahroozian, E., Ahmadi-Hamedani, M., Javaheri-Vayeghan, A., Emadi Chashmi, H.
    • Journal: Archives of Razi Institute, 2021, 76(3), pp. 699–706
  8. Threshold time to onset serum biochemical changes of Turkoman racehorses at different serum-clot contact times and temperatures
    • Authors: Sadeghian, S.K., Ahmadi-Hamedani, M., Yousefi, M.H., Sani, R.N.
    • Journal: Iranian Journal of Veterinary Medicine, 2021, 15(4), pp. 432–439
  9. Protective Effect of Camel Milk on Gentamicin-induced Nephrotoxicity: From Renal Biomarkers to Histopathology Evidence
    • Authors: Arab, F., Naeimi, S., Javaheri-Vayeghan, A., Muhammadnejad, A., Ahmadi-Hamedani, M.
    • Journal: Iranian Journal of Veterinary Medicine, 2021, 15(1), pp. 79–92
    • Citations: 1
  10. Protective effect of flunixin meglumin on changes induced by isoproterenol in serum biochemical profile, malondialdehyde and heart histology of adult male rats
    • Authors: Tahery, S., Ahmadi-Hamedani, M., Keramati, K., Vayghan, A.J., Naeimi, S.
    • Journal: Iranian Journal of Toxicology, 2021, 13(4), pp. 33–37